200
Participants
Start Date
May 1, 2024
Primary Completion Date
March 1, 2025
Study Completion Date
March 1, 2028
ADT combined with abiraterone
The patients will receive long-term ADT combined with abiraterone.
neoadjuvant hormone and RT
The patients will receive 1 month of naADT, followed by metastasis-directed radiation and abdominal or pelvic radiotherapy. Then, radical prostatectomy will be performed at intervals of 5-15 weeks after radiotherapy, and long-term ADT will be continued.
The Second Affiliated Hospital of Naval Medical University, Shanghai
The First Affiliated Hospital of Naval Medical University, Shanghai
Jiangnan University Medical Center, Wuxi
the First Affiliated Hospital of Guangzhou Medical University, Guangzhou
First Affiliated Hospital and Medical College of Soochow University, Suzhou
The First Affiliated Hospital of Ningbo University, Ningbo
Changhai Hospital
OTHER